For the most part, analysts across Wall Street maintained their long-term bullishness on shares of Cadence Design Systems , following its fourth-quarter earnings release, calling threats of artificial intelligence disruption overblown. On Tuesday afternoon, the electronic systems designer reported fourth-quarter adjusted earnings of $1.99 per share, surpassing the $1.91 analysts polled by FactSet had expected. Cadence’s $1.44 billion revenue also exceeded the consensus forecast of $1.42 billion. Cadence estimated full-year earnings will also come in higher than anticipated. Revenue for its current quarter should land between $1.42 billion and $1.46 billion, above analysts’ expectations of $1.38 billion. Cadence has been swept up in the broader software sell-off this year, with the stock down 9% in 2026. But shares were already rebounding 7% higher as analysts applauded Cadence’s protection from AI threats. “While there are general concerns about AI disrupting the software business model, both we and the team believe that chip design software is highly complex and not easily replicated, benefiting from strong technology, a strong customer/ ecosystem network, and a significant data moat. Instead, AI should enable Cadence to unlock better automation capabilities for customers and drive improved monetization,” JPMorgan analyst Harlan Sur wrote. “Cadence noted agentic AI workflows at customers are increasing the use of its software and is not engaged in customer discussions to reduce (electronic design automation). Cadence is adding extra tools to automate the (register transfer level) coding process (manual), while noting the chip design process still requires existing tools such as verification, simulation, etc,” wrote Wells Fargo analyst Joe Quatrochi. “We would view this positively, and we’ll be interested in better understanding Cadence’s ‘usage / outcome-based’ pricing of its AI tools.” Bottom line, most analysts maintained their long-term bullish stance, although some cut their price targets. Here’s how Wall Street’s biggest shops reacted. Piper Sandler: Neutral rating, $319 price target The investment firm’s price target, down from $355, implies about 13% upside from Cadence’s Tuesday close of $283.46. “While all encouraging, including the implicit return of double-digit growth in recurring revenue, we believe shares largely represent, in our view, the fulsome picture of CDNS’s medium-term prospects: low-teens CAGR for revenue and ~50% incremental margins. As seen in recent weeks, carrying a premium multiple in software is challenging proposition. While fundamentals remain robust and think CDNS is the strongest asset in (electronic design automation), we remain Neutral.” Morgan Stanley: Overweight, $370 Morgan Stanley’s forecast, down from $385, corresponds to upside of 31%. “Another beat this quarter, with evidence of momentum into 1H26, likely supports price action. New agentic plays and a sense that systems threats from LLMs are minimal may be more supportive of longer-term value. We keep our Overweight rating but trim our estimates in line with guidance; PT to $370.” Bank of America: Buy, $375 The bank’s target, cut from $400, calls for upside of 32%. “CDNS has seen no customer discussion regarding reducing their usage of EDA software and remain protected by 1) increasing customer reliance on AI expected to increase semi R & D budgets and the % of R & D $s going to (electronic design automation) (currently ~15%) given EDA tool complexity needed to design more complex chips, 2) deep integration with customer design teams/roadmaps increasing customer reliance on CDNS, and 3) chip design data collected over prior years allowing for faster acceleration of CDNS’ AI-enabled tools vs. ‘merchant’ AI models.” Wells Fargo: Overweight, $375 Wells Fargo cut its target from $410. “Positive initial 2026 Guide; focus on upside drivers as recurring software re-accelerates. Cadence delivered a positive beat / raise as it continues to see strong broad-based demand. Strong 1Q26 guide leaves us focused on conservatism for 2026 as CDNS reported re-accelerating recurring software demand in part via AI.” Baird: Outperform, $395 Baird’s forecast is 39% above Cadence’s Tuesday closing price. “Unease ahead of 4Q25 results drove Cadence shares -5% Tuesday (S & P=flat%), there is opportunity to regain lost ground given strength in quarter, AI-related demand improvement, and positive guidance. FY26 outlook begins revenue +11-13% YoY (consensus=12%), recurring revenues accelerating +LDD% YoY, guidance de-risked for contributions from hardware/China (hardware with potential 2H upside as pipeline fills). We expect FY26 growth finishes closer to mid-teens YoY (FY25: +14% YoY), and within tough software tape, we recommend exposure to Cadence given AI positioning and industry-leading growth within each key product segment.” Mizuho: Outperform, $400 Mizuho’s target equates to 41% upside. “Management continues to see healthy design activity, especially stable growth in China against a potentially volatile geopolitical backdrop. Hardware and IP continue to see solid trends and core (electronic design automation) is performing well. CDNS continues to benefit from the GenAI build-outs and internal AI-driven productivity gains while SD & A expansion and emerging Physical AI opportunities add long-term optionality.” JPMorgan: Overweight, $405 JPMorgan’s forecast implies about 43% upside from here. “Solid full-year CY26 guidance reflects prudent China/ hardware outlook; expect more upside as year unfolds on strong AI chip design activity and AI solution adoption … Leading-edge chip design activity is strong, driven by the AI infrastructure build-out and broad-based portfolio strength. Additionally, Cadence’s AI products — Cerebrus, Verisium, and Allegro X AI — are gaining traction, alongside the recently launched agentic AI solution, Chipstack AI Super Agent. Hardware revenues were strong and at record levels, fueled by demand from AI and hyperscale customers, and the team anticipates another record year in CY26.”
This software stock was hit hard on AI disruption fears. Now it’s proving detractors wrong
Leave a comment
